Yang W, Wang X, Yuan H, Liu Z, Gao S, Peng L. Exploring the mechanism of WWOX growth inhibitory effects on oral squamous cell carcinoma.. Oncol Lett. 2017;13:3198-3204 pubmed publisher

Litwin M, Radwanska A, Paprocka M, Kieda C, Dobosz T, Witkiewicz W, et al. The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production. Mol Cell Biochem. 2015;410:131-42 pubmed publisher

Chadashvili T, Peterson D. Cytoarchitecture of fibroblast growth factor receptor 2 (FGFR-2) immunoreactivity in astrocytes of neurogenic and non-neurogenic regions of the young adult and aged rat brain. J Comp Neurol. 2006;498:1-15 pubmed

Smith J, Quinones-Hinojosa A, Harmon-Smith M, Bollen A, McDermott M. Sex steroid and growth factor profile of a meningioma associated with pregnancy. Can J Neurol Sci. 2005;32:122-7 pubmed

Dutt A, Salvesen H, Chen T, Ramos A, Onofrio R, Hatton C, et al. Drug-sensitive FGFR2 mutations in endometrial carcinoma. Proc Natl Acad Sci U S A. 2008;105:8713-7 pubmed publisher

Loilome W, Joshi A, ap Rhys C, Piccirillo S, Vescovi A, Angelo V, et al. Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling. J Neurooncol. 2009;94:359-66 pubmed publisher

Martin L, Assif N, Gilbert M, Wijewarnasuriya D, Seandel M. Enhanced fitness of adult spermatogonial stem cells bearing a paternal age-associated FGFR2 mutation. Stem Cell Reports. 2014;3:219-26 pubmed publisher

Smith J, Lal A, Harmon-Smith M, Bollen A, McDermott M. Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma. J Neurosurg. 2007;106:1034-40 pubmed